[EN] HEMI (L)-TARTRATE FORMS OF 3-({5-CHLORO-1-[3-(METHYLSULFONYL)PROPYL]-1H-INDOL-2 YL} METHYL)-1-(2,2,2-TRIFLUOROETHYL)-1,3-DIHYDRO-2H-IMIDAZO[4,5-C]PYRIDIN-2-ONE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME<br/>[FR] FORMES D'HÉMI-(L)-TARTRATE DE 3-({5-CHLORO-1-[3-(MÉTHYLSULFONYL)PROPYL]-1 H-INDOL-2 YL}MÉTHYL)-1-(2,2,2-TRIFLUOROÉTHYL)-1,3-DIHYDRO-2H-IMIDAZO[4,5-C]PYRIDIN-2-ONE ET COMPOSITIONS PHARMACEUTIQUES LES COMPRENANT
申请人:JANSSEN SCIENCES IRELAND UNLIMITED CO
公开号:WO2021250180A1
公开(公告)日:2021-12-16
The present invention relates to hemi (L)-tartrate forms of the RSV fusion inhibitor 3-(5-chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H- imidazo[4,5-c]pyridin-2-one (also known under its INN as rilematovir), and to processes for preparing said forms and the use of these forms in a pharmaceutical composition.